1,416
Views
1
CrossRef citations to date
0
Altmetric
Letter

Editorial on “What is a potentially damaging vaccination delay in children younger than 2 years?”

, , , , &
Pages 2053-2056 | Received 23 Mar 2016, Accepted 08 Apr 2016, Published online: 03 Jun 2016

References

  • Cooke GS, Lemoine M, Thursz M, Gore C, Swan T, Kamarulzaman A, DuCros P, Ford N. Viral Hepatitis and the global burden of disease. a need to regroup. J Viral Hepat 2013; 20(9):600-1; PMID:23910643; http://dx.doi.org/10.1111/jvh.12123
  • World Health Organization. Immunization Coverage. Fact Sheet no 378 updated Sept 2015. Accessed at http://www.who.int/mediacentre/factsheets/fs378/en/ on 19 March 2016
  • McGlynn KA, Petrick JL, London WT. Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability. Clin Liver Dis 2015 May; 19(2):223-38; PMID:25921660; http://dx.doi.org/10.1016/j.cld.2015.01.001
  • Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet 2015 Jul 28; S0140–6736(15):61412
  • Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380(9859):2095-28; PMID:23245604; http://dx.doi.org/10.1016/S0140-6736(12)61728-0
  • McMahon BJ. The natural history of chronic hepatitis B virus infection. Hepatology 2009; 49:S45-S55; PMID:19399792; http://dx.doi.org/10.1002/hep.22898
  • Mast EE, Ward JW. Hepatitis B vaccines. In: Plotkin SA, Orenstein WA, Offit PA, eds. Vaccines, 5th eds. Oxford, Saunders Elsevier, 2008
  • Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y, Liu J, Gong X, Chen Y, et al. Evaluation of the impact of hepatitis B vaccination among children born during 1992-2005 in China. J Infect Dis 2009 Jul 1; 200(1):39-47; PMID:19469708; http://dx.doi.org/10.1086/599332
  • European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of chronic hepatitis B virus infection. J Hepatol 2012; 57:167-85; PMID:22436845; http://dx.doi.org/10.1016/j.jhep.2012.02.010
  • European Association for the Study of the Liver. EASL Recommendations on Treatment of Hepatitis C. J Hepatol 2015; 63(1):199-236; PMID:25911336; http://dx.doi.org/10.1016/j.jhep.2015.03.025
  • Gras P, Bailly AC, Lagree M, et al. What timing of vaccination is potentially dangerous for children younger than 2 years? Hum Vacc Therapeutics 2016; http://dx.doi.org/10.1080/21645515.2016.1177689
  • Institut de Veille Sanitare. Analyse detaillee des donnees epidemiologiques sur l'hepatiteB; 2015. (accessed March 17, 2016) http://www.invs.sante.fr/Dossiers-thematiques/Maladies-infectieuses/Hepatites-virales/Hepatiti-B
  • World Health Organization. Global Health Observatory data repository. Hepatitis B data by country. Accessed at http://apps.who.int/gho/data/node.main.A828 on 17 March 2016
  • Papaevangelou V, Hadjichristodoulou C, Cassimos D, Theodoridou M. Adherence to the screening program for HBV infection in pregnant women delivering in Greece. BMC Infect Dis 2006 May 9; 6:84; PMID:16681862; http://dx.doi.org/10.1186/1471-2334-6-84
  • Karatapanis S, Skorda L, Marinopoulos S, Papastergiou V, Drogosi M, Lisgos P, Antsaklis A. Higher rates of chronic hepatitis B infection and low vaccination-induced protection rates among parturients escaping HBsAg prenatal testing in Greece: a 2-year prospective study. Eur J Gastroenterol Hepatol 2012 Aug; 24(8):878-83; PMID:22588307; http://dx.doi.org/10.1097/MEG.0b013e328354834f
  • World Health Organization. Hepatitis B Vaccines. WHO Position Paper. Weekly Epidemiologic Record No. 40 2009; 84:405-20. http://www.who.int/wer
  • Franks AL, Berg CJ, Kane MA, Browne BB, Sikes RK, Elsea WR, Burton AH. Hepatitis B virus infection in US born children of Southeast Asian refugees. N Engl J Med 1989; 321(19):1301-5; PMID:2797103; http://dx.doi.org/10.1056/NEJM198911093211905
  • FitzSimons D, Vorsters A, Hoppenbrouwers K, VanDamme P. Prevention and control of viral hepatitis through adolescent health programmes in Europe. Vaccine 2007; 25(52), 17 December:8651-9; PMID:18036709; http://dx.doi.org/10.1016/j.vaccine.2007.10.005
  • Fonteneau L, Ragot M, Guthmann JP, Lévy-Bruhl D. Use of health care reimbursement data to estimate vaccination coverage in France: Example of hepatitis B, meningitis C, and human papillomavirus vaccination. Rev Epidemiol Sante Publique 2015 Oct; 63(5):293-8; PMID:26386634; http://dx.doi.org/10.1016/j.respe.2015.06.005
  • Confavreux C, Suissa S, Saddier P, Bourdès V, Vukusic S. Vaccines in Multiple Sclerosis Study Group. Vaccinations and the risk of relapse in multiple sclerosis. N Engl J Med 2001 Feb 1; 344(5):319-26; PMID:11172162; http://dx.doi.org/10.1056/NEJM200102013440501
  • Institute of Medicine. Immunization Safety Review: Hepatitis B Vaccine and Demyelinating Neurological Disorders. Washington DC; 2002
  • Stahl JP, Denis F, Gaudelus J, Cohen R, Lepetit H, Martinot A. Hepatitis B vaccination and adolescents: A lost generation. Med Mal Infect 2016 Feb; 46(1):1-3; PMID:26746325; http://dx.doi.org/10.1016/j.medmal.2015.11.002

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.